UniSa - IRIS Institutional Research Information System

ESPOSITO, Carla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.572
EU - Europa 1.955
AS - Asia 1.350
SA - Sud America 224
AF - Africa 13
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.119
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.509
CN - Cina 514
IT - Italia 498
UA - Ucraina 492
SG - Singapore 391
DE - Germania 262
VN - Vietnam 219
RU - Federazione Russa 218
BR - Brasile 207
FI - Finlandia 154
IE - Irlanda 139
TR - Turchia 78
SE - Svezia 68
FR - Francia 47
KR - Corea 42
MX - Messico 32
IN - India 29
CA - Canada 23
GB - Regno Unito 23
HK - Hong Kong 23
CZ - Repubblica Ceca 13
BD - Bangladesh 9
IQ - Iraq 9
ES - Italia 6
IL - Israele 6
PK - Pakistan 6
AR - Argentina 5
AT - Austria 5
PL - Polonia 5
PH - Filippine 4
RS - Serbia 4
ZA - Sudafrica 4
AL - Albania 3
CL - Cile 3
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
UZ - Uzbekistan 3
AU - Australia 2
BG - Bulgaria 2
EC - Ecuador 2
HN - Honduras 2
JM - Giamaica 2
JP - Giappone 2
KE - Kenya 2
LT - Lituania 2
NL - Olanda 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 9.119
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 596
Princeton 393
Houston 260
Dong Ket 210
Woodbridge 209
Ashburn 179
Singapore 169
Munich 139
Dublin 136
Boardman 111
Nanjing 110
Dearborn 107
Beijing 104
Andover 97
Pellezzano 76
Salerno 65
Izmir 62
Mestre 49
Moscow 49
Fairfield 41
Helsinki 40
Redwood City 37
Nanchang 35
Hebei 33
Shenyang 33
Changsha 27
Hong Kong 23
Tianjin 21
Jiaxing 20
Pune 19
Dallas 18
Los Angeles 16
Napoli 16
Sant'agata De' Goti 16
São Paulo 16
Washington 15
Cuauhtémoc 14
Agropoli 13
Brno 12
Norwalk 12
Cava 11
Düsseldorf 11
Ottawa 11
San Diego 11
Turku 11
Belo Horizonte 9
Guangzhou 9
Istanbul 9
Lessolo 9
Seattle 9
Naples 8
New York 8
Phoenix 8
Potenza 8
Rio de Janeiro 8
Spinea 8
The Dalles 8
Bari 7
Caserta 7
Jinan 6
Kunming 6
Marsico Nuovo 6
Bologna 5
Boston 5
Brooklyn 5
Hefei 5
Portici 5
Santa Clara 5
Shanghai 5
Springfield 5
Vienna 5
Warsaw 5
Atlanta 4
Belgrade 4
Brasília 4
Cambridge 4
Columbus 4
Curitiba 4
Dormagen 4
Guarulhos 4
La Paz 4
Lequile 4
London 4
Montreal 4
Stockholm 4
Venezia 4
Zhengzhou 4
Amman 3
Ankara 3
Buffalo 3
Charlotte 3
Chicago 3
Congonhas 3
Falls Church 3
Ferrara 3
Fisciano 3
Fortaleza 3
Totale 6.574
Salva come PNG Salva come JPEG
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 220
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 144
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 141
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 139
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 137
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 133
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 129
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 128
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 127
Application of a computational approach to identify protein targets for 4-nonylphenol 125
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 123
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 120
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 119
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 119
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 116
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 116
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 115
Analysis of transglutaminase protein substrates by functional proteomics. 113
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 113
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 112
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 111
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 109
Tissue transglutaminase in celiac disease: role of autoantibodies. 108
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 108
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 104
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 104
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 102
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 102
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 100
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 99
null 98
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 98
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 98
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 97
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 97
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 96
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 95
Transglutaminase 2 in celiac diasease: Minireview article 94
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 93
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 93
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 92
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 92
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 90
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 90
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 87
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 86
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 85
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 85
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 83
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 83
Tissue Transglutaminase and Coeliac Disease. 81
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 81
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 80
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 80
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 80
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 80
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 79
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 79
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 79
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 77
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 77
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 76
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 76
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 76
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 76
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 74
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 73
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 72
null 71
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 71
Searching for the protein targets of 4-nonylphenol using a computational approach 71
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 70
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 69
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 69
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 68
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 68
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 68
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 68
null 67
Effects of Methyl Bromide on activity of blood coagulation enzymes 67
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 66
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 66
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 65
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 65
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 65
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 64
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 62
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 62
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 61
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 60
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 60
Desmoplakin acts as transglutaminase substrate in vitro. 59
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 58
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 58
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 57
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 57
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 55
Coeliac disease and extraintestinal autoimmunity. 54
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 54
Rat prostate transglutaminase: biochemical properties of recombinant forms expressed into COS-1 cells 52
Totale 8.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021986 5 97 107 5 132 37 112 9 132 13 115 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/2026137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 9.329